Skip to main content

Animations

MJFF Publications

5711 - 5720 of 8808 Results
Title
Year
  • Year
  • 2025
  • 2022
  • 2025
  • 2021
  • 2024
  • 2024
  • 2023
  • 2021
  • 2022
  • 2022
  • Summary Details
    OPEN
    Title: α-Synuclein seed amplification assay positivity beyond synucleinopathies
    Journal Name: eBioMedicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.ebiom.2025.105925
    Citation Count: 0
  • Summary Details
    OPEN
    Title: A comparison of methods to harmonize cortical thickness measurements across scanners and sites
    Journal Name: NeuroImage
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuroimage.2022.119509
    Citation Count: 36
  • Summary Details
    OPEN
    Title: A common mechanism of singular gene choice is revealed by broadly expressed odorant receptor transgenes within the olfactory epithelium
    Journal Name: Cell Reports
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.celrep.2025.115955
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Reference SVA insertion polymorphisms are associated with Parkinson’s Disease progression and differential gene expression
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-021-00189-4
    Citation Count: 45
  • Summary Details
    OPEN
    Title: Genome-wide analyses reveal a potential role for the MAPT, MOBP, and APOE loci in sporadic frontotemporal dementia
    Journal Name: The American Journal of Human Genetics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.ajhg.2024.05.017
    Citation Count: 7
  • Summary Details
    OPEN
    Title: A comprehensive head-to-head comparison of key plasma phosphorylated tau 217 biomarker tests
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1093/brain/awae346
    Citation Count: 29
  • Summary Details
    OPEN
    Title: B lymphocyte responses in Parkinson’s disease and their possible significance in disease progression
    Journal Name: Brain Communications
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1093/braincomms/fcad060
    Citation Count: 23
  • Summary Details
    RESTRICTED
    Title: Effect of the glycine transporter 1 inhibitor ALX-5407 on dyskinesia, psychosis-like behaviours and parkinsonism in the MPTP-lesioned marmoset
    Journal Name: European Journal of Pharmacology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.ejphar.2021.174452
    Citation Count: 15
  • Summary Details
    OPEN
    Title: A data-driven model of brain volume changes in progressive supranuclear palsy
    Journal Name: Brain Communications
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1093/braincomms/fcac098
    Citation Count: 18
  • Summary Details
    OPEN
    Title: Generation of homozygous PRKN, PINK1 and double PINK1/PRKN knockout cell lines from healthy induced pluripotent stem cells using CRISPR/Cas9 editing
    Journal Name: Stem Cell Research
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.scr.2022.102806
    Citation Count: 13
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.